Premarket Mover: Nuvation Bio Inc (NUVB) Down 3.13%

Nuvation Bio Inc (NUVB) has fallen Tuesday morning, with the stock losing -3.13% in pre-market trading to 1.24. NUVB's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, NUVB ranks higher than 55% of stocks. Nuvation Bio Inc has risen 9.40% over the past month, closing at $1.20 on October 17. During this period of time, the stock fell as low as $0.96 and as high as $1.38. NUVB has an average analyst recommendation of Strong Buy. The company has an average price target of $3.98.

NUVB has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on NUVB!

See Full NUVB Report

Nuvation Bio Inc has a Long-Term Technical rank of 11. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 89% of the market scoring higher. In the Biotechnology industry which is number 126 by this metric, NUVB ranks better than 126% of stocks.

Important Dates for Investors in NUVB:

-Nuvation Bio Inc is set to release earnings on 2024-01-31. Over the last 12 months, the company has reported EPS of $-0.41. -We do not have a set dividend date for Nuvation Bio Inc at this time. Click Here To Get The Full Report on Nuvation Bio Inc (NUVB)